Cargando…

NK Cell-Based Immunotherapy in Renal Cell Carcinoma

Natural killer (NK) cells are cytotoxic lymphocytes that are able to kill tumor cells without prior sensitization. It has been shown that NK cells play a pivotal role in a variety of cancers, highlighting their relevance in tumor immunosurveillance. NK cell infiltration has been reported in renal ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Terrén, Iñigo, Orrantia, Ane, Mikelez-Alonso, Idoia, Vitallé, Joana, Zenarruzabeitia, Olatz, Borrego, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072691/
https://www.ncbi.nlm.nih.gov/pubmed/32013092
http://dx.doi.org/10.3390/cancers12020316
_version_ 1783506465533722624
author Terrén, Iñigo
Orrantia, Ane
Mikelez-Alonso, Idoia
Vitallé, Joana
Zenarruzabeitia, Olatz
Borrego, Francisco
author_facet Terrén, Iñigo
Orrantia, Ane
Mikelez-Alonso, Idoia
Vitallé, Joana
Zenarruzabeitia, Olatz
Borrego, Francisco
author_sort Terrén, Iñigo
collection PubMed
description Natural killer (NK) cells are cytotoxic lymphocytes that are able to kill tumor cells without prior sensitization. It has been shown that NK cells play a pivotal role in a variety of cancers, highlighting their relevance in tumor immunosurveillance. NK cell infiltration has been reported in renal cell carcinoma (RCC), the most frequent kidney cancer in adults, and their presence has been associated with patients’ survival. However, the role of NK cells in this disease is not yet fully understood. In this review, we summarize the biology of NK cells and the mechanisms through which they are able to recognize and kill tumor cells. Furthermore, we discuss the role that NK cells play in renal cell carcinoma, and review current strategies that are being used to boost and exploit their cytotoxic capabilities.
format Online
Article
Text
id pubmed-7072691
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70726912020-03-19 NK Cell-Based Immunotherapy in Renal Cell Carcinoma Terrén, Iñigo Orrantia, Ane Mikelez-Alonso, Idoia Vitallé, Joana Zenarruzabeitia, Olatz Borrego, Francisco Cancers (Basel) Review Natural killer (NK) cells are cytotoxic lymphocytes that are able to kill tumor cells without prior sensitization. It has been shown that NK cells play a pivotal role in a variety of cancers, highlighting their relevance in tumor immunosurveillance. NK cell infiltration has been reported in renal cell carcinoma (RCC), the most frequent kidney cancer in adults, and their presence has been associated with patients’ survival. However, the role of NK cells in this disease is not yet fully understood. In this review, we summarize the biology of NK cells and the mechanisms through which they are able to recognize and kill tumor cells. Furthermore, we discuss the role that NK cells play in renal cell carcinoma, and review current strategies that are being used to boost and exploit their cytotoxic capabilities. MDPI 2020-01-29 /pmc/articles/PMC7072691/ /pubmed/32013092 http://dx.doi.org/10.3390/cancers12020316 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Terrén, Iñigo
Orrantia, Ane
Mikelez-Alonso, Idoia
Vitallé, Joana
Zenarruzabeitia, Olatz
Borrego, Francisco
NK Cell-Based Immunotherapy in Renal Cell Carcinoma
title NK Cell-Based Immunotherapy in Renal Cell Carcinoma
title_full NK Cell-Based Immunotherapy in Renal Cell Carcinoma
title_fullStr NK Cell-Based Immunotherapy in Renal Cell Carcinoma
title_full_unstemmed NK Cell-Based Immunotherapy in Renal Cell Carcinoma
title_short NK Cell-Based Immunotherapy in Renal Cell Carcinoma
title_sort nk cell-based immunotherapy in renal cell carcinoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072691/
https://www.ncbi.nlm.nih.gov/pubmed/32013092
http://dx.doi.org/10.3390/cancers12020316
work_keys_str_mv AT terreninigo nkcellbasedimmunotherapyinrenalcellcarcinoma
AT orrantiaane nkcellbasedimmunotherapyinrenalcellcarcinoma
AT mikelezalonsoidoia nkcellbasedimmunotherapyinrenalcellcarcinoma
AT vitallejoana nkcellbasedimmunotherapyinrenalcellcarcinoma
AT zenarruzabeitiaolatz nkcellbasedimmunotherapyinrenalcellcarcinoma
AT borregofrancisco nkcellbasedimmunotherapyinrenalcellcarcinoma